Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Bruised not broken

Judo Capital Holdings
3:27pm
May 1, 2025
Following JDO’s Q3 trading update, we have downgraded our FY26+ earnings forecasts by c.11% principally due to slower build-up of gross loan balances and higher FY26+ costs than previously assumed. We align our FY25 and FY26 PBT forecasts with JDO’s guidance for 15% and 50% growth respectively, and we forecast c.40% growth in FY27F (loan growth, NIM expansion, operating leverage). Our 12 month target price reduces 16% to $1.75 per share, with the key drivers being the lower earnings growth outlook flowing into a lower terminal ROE (we now don’t expect JDO to achieve its at-scale ROE target of low-to-mid teens). While we make a material earnings forecast downgrade, the share price downgrade has been even harsher. We estimate the stock is currently trading on a P/E of c.12x (FY26F) and c.1x P/BV (end-FY25F). ADD retained.

The start of a new look

Baby Bunting Group
3:27pm
May 1, 2025
BBN provided a trading update for 2H YTD sales, with LFL sales growth of +3.7%, implying an acceleration from the first 7 weeks which was up 2.8%. Gross margins were 40% YTD, in line with guidance. BBN also firmed up their guidance range, increasing the bottom end slightly, with pro forma NPAT expected to be between $10-12.5m (from $9.5m-12.5m). BBN unveiled its “Store of the Future” at its newly refurbished Maribyrnong store, a key part of its revised strategy in order to return the business to 10% EBITDA margins. We have made very minor changes to our forecasts, and have decreased our valuation to $1.80 (from $1.90) based on lower peer multiples. Hold rating retained.

Smashing expectations

AMA Group
3:27pm
May 1, 2025
AMA reported a positive 3Q25 update, delivering EBITDA growth of 79% (cont. ops) on improved 8.9% EBITDA margins (vs ~5.4% in 1H25). FY25 EBITDA guidance of A$58-62m implies ~22% yoy growth (at mid-point). The aspirational med-term EBITDA margin target has been raised to 10% and brought forward to be achieved in the “forthcoming years” (previously set for FY29). A strong update from AMA, reinforcing our positive view and raising our near-term growth expectations. We see strong upside as the turnaround gains momentum and sit comfortably within the group’s 10% margin target. Add maintained.

Some encouraging signs but BIG W remains a drag

Woolworths
3:27pm
May 1, 2025
WOW’s 3Q25 sales trading update was slightly above our expectations with solid performance across most divisions. The key negative however was BIG W with sales growth reliant on clearance of spring/summer stock and a slower start to autumn/winter. This has impacted margins with management now expecting BIG W 2H25 EBIT of around -$70m (vs -$40m previously). Management said customers continue to seek value as household budgets remain under pressure. We adjust FY25-27F group EBIT by between -1% and 0% with the key change being a reduction in BIG W earnings forecasts to reflect updated guidance. Our target price increases to $31.80 (from $31.00) as the solid performance of Australian Food gives us a bit more confidence that the business may be turning the corner after a difficult 12-18 months. Hold rating maintained.

Momentum looks to be building offshore

Airtasker
3:27pm
April 30, 2025
ART’s 3Q25 trading update was highlighted by the solid momentum seen in its offshore marketplaces post the ramp up of marketing investment in recent periods. Group revenue increased ~12% on the pcp to A$13.6m (22.3% monetisation rate). The key takeaways in the update, in our view, being the strong pcp TTM GMV growth rate in the UK of ~64%, along with a UK GMV ARR of A$16.5m. We update our forecasts to factor in the recent trading update, with only marginal changes (-1 to -2%) to our topline estimates over FY25-FY27. Our DCF/multiples derived price target is A$0.55 (from A$0.56) on these changes. Add maintained.

Long-term prospects remain solid

Acrow
3:27pm
April 30, 2025
ACF has acquired two businesses in the Industrial Access space for a total consideration of $29m (including earn-out payments). This implies an EV/EBITDA multiple of ~4x (before synergies), which is consistent with management’s target for acquisitions. Management has decreased FY25 earnings guidance due to ongoing project delays. We see this as largely a timing issue with EBITDA of ~$9m pushed into FY26. Factoring in the acquisitions and updated earnings guidance sees FY25/26/27F EBITDA change by -4%/+3%/+2%. Our target price remains unchanged at $1.32 and we maintain our Add rating. While project delays are impacting earnings in FY25, year-to-date (YTD) secured hire contract wins (a key leading indicator of future performance) jumped 35%. This suggests to us that the pipeline remains strong and will underpin solid growth for ACF when activity picks up (particularly in QLD as infrastructure projects associated with the Brisbane Olympics need to start soon to be ready for the event in 2032).

Performing well

Coles Group
3:27pm
April 30, 2025
COL’s 3Q25 sales trading update overall was largely in line with expectations. Supermarkets sales rose 3.7% (vs MorgansF +3.5%) while Liquor sales increased 3.4% (vs MorgansF +3.3%). Management said Supermarkets sales growth in early 4Q25 has remained broadly in line with 3Q25 while Liquor growth remained positive. We make minimal changes to group earnings forecasts. Our target price stays broadly unchanged at $20.95 (vs $20.90 previously) and we maintain our Hold rating. While COL continues to execute well with good sales momentum and ongoing efficiency benefits from the automated distribution centres and customer fulfilment centres, trading on 22.1x FY26F PE and 3.6% yield we see the valuation as full. We may look to reassess our view on share price weakness.

Update for March 2025 CPI

Dalrymple Bay Infrastructure
3:27pm
April 30, 2025
DBI’s share price has had an outstanding run, with investors most recently attracted to its low beta/defensive attributes during a period of flight to quality/certainty given global economic uncertainties. We also believe DBI has benefitted from the release of the coal ESG discount that had previously been imputed into its share price. While the March 2025 CPI released today was less than we had assumed in our modelling, it nonetheless supports ongoing earnings and distribution growth. We continue to see value in the stock. At the current share price, we estimate a 12 month forward cash yield of c.5.8% (partly franked) and c.6% potential capital growth to our revised price target of $4.35/sh. ADD retained.

Microba looks to Xplore US market

Microba Life Sciences
3:27pm
April 30, 2025
MAP reported its 3Q25 report. Key focus sits with testing volume growth with major in-house tests continuing to show compelling market dynamics and traction. MetaXplore has shown impressive account growth and strong volumes at stable prescriber rates. It’s clear the tests are resonating with prescribers and patients. Coupled with full market access in the UK over the coming months and preliminary plans to enter the US market, we see MAP as well positioned for continued growth. Our valuation and target price has reduced marginally to A$0.32 (from A$0.34) but we retain our Speculative Buy recommendation.

3Q25 Result

Regis Resources
3:27pm
April 30, 2025
RRL released its 3Q25 results following pre-reporting, highlighting another strong quarter across production, costs, and cashflow. Production and sales of 89.6koz and 80.9koz, respectively, keep the company on track to comfortably meet FY25 guidance, demonstrating operational consistency and delivery against stated targets. During the quarter, RRL repaid its remaining A$300m debt ahead of schedule and ended the March quarter with A$367m in net cash. We maintain our ADD rating with a target price of A$4.80 per share (previously A$4.65).

News & Insights

The US economy is growing strongly at 2.34% in Q2 2025 but is expected to slow to 1.4% in 2025, with falling interest rates and a weaker US dollar likely to boost commodity prices, benefiting Australian markets. Michael Knox discusses.

We think the US economy is currently experiencing solid growth, with data from the Chicago Fed  National Activity Index indicating an annual growth rate of just above  2%. This aligns with projections from other parts of the Federal Reserve System, such as the New York Fed. The New York Fed’s weekly Nowcast, updated every Friday, estimates that for the second quarter of 2025, the US economy is growing at an annualised rate of 2.34%, surpassing the 2% mark. This robust growth is consistent with our model’s view that the US economy is now performing strongly. However, we anticipate a slowdown in the second half of 2025.

On 18 June the Fed released its Summary of Economic Projections  with the Federal Reserve’s  forecasting US GDP growth to drop to 1.4% in 2025, down from their March estimate of 1.7%. Looking further ahead, growth is expected to pick up slightly to 1.6% in 2026 and 1.8% in 2027, aligning with the long-term trend growth rate of around 1.8%. We believe this recovery trend could be even  higher,  driven by reduced regulation under the second Trump administration and aggressive tax write-offs for companies building factories in the US, allowing 100% write-offs for equipment and buildings in the first year. This policy should foster stronger systemic growth.

Economic Projections of the Federal Reserve

The Fed expects that as the economy slows,  unemployment is projected to rise to 4.5% from the current level of 4.2%. Inflation, measured by the Consumer Price Index (CPI), is running at 3.5% this year, approximately 50 basis points higher than the Personal Consumption Expenditures (PCE) index of 3.0%, with 1.6% of this  inflation  attributed to tariffs. The Fed expects PCE Inflation  to ease to 2.4% in 2026 and 2.1% in 2027. The Federal Reserve anticipates cutting the effective  federal funds rate, currently at 433 basis points (according to the New York Fed), by 50 basis points by the end of 2025, followed by an additional 25 basis points in each of the next two years. This aligns with our own Fed Funds rate  model’s current equilibrium federal funds rate of  3.85% . The Fed Outlook  supports our scenario of a slowing US economy and rate cuts in the second half of 2025 and beyond. A falling US dollar is then expected to exert upward pressure on commodity prices, benefiting Australian Equity markets.

Taking questions during the Press Conference after releasing the Fed statement  ,Federal Reserve Chair Jay Powell,   addressed the certainty and uncertainty surrounding the inflationary effects of tariffs. Initially, at the start of 2025, the inflationary impact of tariff policies was unclear, but three months of favourable inflation data have provided this clarity, indicating that the inflationary effects are less severe than anticipated. Powell noted that the Feds own uncertainty on the inflationary effects of  tariffs  peaked in April 2025, and the Federal Reserve now has a clearer understanding that  the inflation effects, are lower than initially expected.

The Fed view  supports our own scenario of a slowing US economy in the second half of 2025, allowing for Fed rate cuts  . This in turn should then lead to  a falling US dollar, which we in turn  expect to drive rising commodity prices.

Read more
The Your Wealth publication is our half yearly scrutiny into current affairs for wealth management. Our latest Issue 29 is out now.

The second half of 2025 will be an interesting time for everyone. Geopolitical uncertainty prevails. How will all of this impact the Australian investor and in particular, their wealth and retirement savings? Whether you are an accumulator, saving for short- and long-term goals, or a retiree, hoping for a comfortable retirement, the ability to manage this uncertainty will be key.

When we published the previous Your Wealth – First Half 2025, the Division 296 Bill (Div296) was also facing uncertainty. The Bill was eventually blocked in the Senate prior to the Federal Election. The Labor Party succeeded in winning so it’s Ground Hog Day for Div296. The Government doesn’t have the numbers in the Senate to pass the Bill without support from other parties. The Greens are the likely negotiating party but will undoubtably have their own agenda. Regardless, there is a high probability this legislation will be passed once Parliament resumes.

Our message to our clients is to wait until we know more details and to not act in haste.

In addition to our Feature Article which provides further insights on Div296, this edition also Spotlights the Aged Care changes due this year, with the start date pushed back to 1 November.

We hope readers enjoy this edition of Your Wealth.


Morgans clients receive exclusive insights such as access to our latest Your Wealth publication. Contact us today to begin your journey with Morgans.

      
Contact us
      
Read more
Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more